Thyroid-stimulating immunoglobulins in neonatal Graves's disease.
作者信息
Teng C S, Tong T C, Hutchison J H, Yeung R T
出版信息
Arch Dis Child. 1980 Nov;55(11):894-5. doi: 10.1136/adc.55.11.894.
Abstract
Two patients with neonatal Graves's disease are reported. One of them had a delayed onset because of suppression of the fetal thyroid gland by antithyroid drug taken by the mother during pregnancy. Thyroid-stimulating immunoglobulins (TSAb), measured by a receptor assay, were present in both babies when they were thyrotoxic, and also in their mothers. TSAb were undetectable in both babies 1 year after birth. This strongly supports a pathogenetic role of TSAb in this condition through transplacental transfer of maternal TSAb.
摘要
相似文献
1
Thyroid-stimulating immunoglobulins in neonatal Graves's disease.
Arch Dis Child. 1980 Nov;55(11):894-5. doi: 10.1136/adc.55.11.894.
2
Predictive value of maternal second-generation thyroid-binding inhibitory immunoglobulin assay for neonatal autoimmune hyperthyroidism.
Eur J Endocrinol. 2014 Oct;171(4):451-60. doi: 10.1530/EJE-14-0254.
3
The role of thyroid stimulating immunoglobulins of Graves's disease in neonatal thyrotoxicosis.
Br J Obstet Gynaecol. 1978 Nov;85(11):837-43. doi: 10.1111/j.1471-0528.1978.tb15839.x.
4
Differences between changes in serum thyrotropin-binding inhibitory antibodies and thyroid-stimulating antibodies in the course of antithyroid drug therapy for Graves' disease.
Thyroid. 1999 Aug;9(8):769-73. doi: 10.1089/thy.1999.9.769.
5
Pregnancy-associated changes in the thyroid-stimulating antibody of Graves' disease and the relationship to neonatal hyperthyroidism.
J Clin Endocrinol Metab. 1983 Nov;57(5):1036-40. doi: 10.1210/jcem-57-5-1036.
6
Foetal and neonatal thyroid disorders.
Minerva Pediatr. 2002 Oct;54(5):383-400.
7
Specific effects of radioiodine treatment on TSAb and TBAb levels in patients with Graves' disease.
Thyroid. 1995 Jun;5(3):171-6. doi: 10.1089/thy.1995.5.171.
8
Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles.
Thyroid. 1999 Oct;9(10):979-88. doi: 10.1089/thy.1999.9.979.
9
Interaction of thyroid-stimulating antibody with Graves' thyroid-stimulating hormone-binding antibody.
Horm Res. 2003;59(5):222-8. doi: 10.1159/000070221.
10
[Thyroid stimulating antibodies in pregnant women with Graves' disease and neonatal thyrotoxicosis].
Ugeskr Laeger. 1997 Feb 17;159(8):1086-9.
引用本文的文献
1
Transient neonatal hyperthyroidism and maternal thyroid stimulating immunoglobulins.
Arch Dis Child. 1988 Feb;63(2):205-7. doi: 10.1136/adc.63.2.205.
2
Clinical applications of assays for thyrotropin-receptor antibodies in Graves' disease.
CMAJ. 1986 May 15;134(10):1141-7.
本文引用的文献
1
Changes in thyroid-stimulating antibody activity in Graves' disease treated with antithyroid drug and its relationship to relapse: a prospective study.
J Clin Endocrinol Metab. 1980 Jan;50(1):144-7. doi: 10.1210/jcem-50-1-144.
2
Thyroid-stimulating immunoglobulins in Graves' disease.
Lancet. 1974 Aug 24;2(7878):427-31. doi: 10.1016/s0140-6736(74)91815-7.
3
Placental transmission of thyroid-stimulating immunoglobulins.
Br Med J. 1975 Jun 21;2(5972):665-6. doi: 10.1136/bmj.2.5972.665.
4
Neonatal thyrotoxicosis is associated with transplacental passage of human thyroid stimulating immunoglobulin (HTSI).
Arch Dis Child. 1976 Jul;51(7):565-7. doi: 10.1136/adc.51.7.565.
5
Relation of thyroid-stimulating immunoglobulins to thyroid function and effects of surgery, radioiodine, and antithyroid drugs.
Lancet. 1975 Mar 29;1(7909):713-5. doi: 10.1016/s0140-6736(75)91629-3.
Zotero 插件